Attached files
file | filename |
---|---|
8-K - FORM 8-K - METLIFE INC | y89998e8vk.htm |
MetLife, Inc.
Unaudited Pro Forma Condensed Combined Statement of Operations
Unaudited Pro Forma Condensed Combined Statement of Operations
On November 1, 2010, MetLife, Inc. acquired all of the outstanding shares of capital stock of
American Life Insurance Company and Delaware American Life Insurance Company (together, ALICO)
for a total purchase price of approximately $16.4 billion, subject to adjustment, which included
cash of $7.2 billion and securities of MetLife, Inc. valued at $9.2 billion (the Acquisition).
The Acquisition was made pursuant to a stock purchase agreement, as amended, dated as of March 7,
2010 by and among MetLife, Inc., American International Group, Inc. (AIG) and ALICO Holdings LLC
(ALICO Holdings) (the Stock Purchase Agreement).
The unaudited pro forma condensed combined statement of operations and accompanying notes present
the impact of the Acquisition on MetLife, Inc.s results of operations under the acquisition method
of accounting. The unaudited pro forma condensed combined statement of operations for the year
ended December 31, 2010 combines the historical consolidated statement of operations of MetLife,
Inc. for the year ended December 31, 2010 (which includes ALICOs operations for the month of
November 2010) with the historical combined statement of income of ALICO for the eleven months
ended October 31, 2010, giving effect to the Acquisition as if it had been completed on January 1,
2010. The historical financial information has been adjusted in the unaudited pro forma condensed
combined statement of operations to give effect to pro forma events that are directly attributable
to the Acquisition and factually supportable, and are expected to have a continuing impact on the
combined results.
The unaudited pro forma condensed combined statement of operations should be read in conjunction
with the accompanying notes and in conjunction with the audited historical consolidated financial
statements of MetLife, Inc. as of and for the year ended December 31, 2010 and the related notes,
included in MetLife, Inc.s Annual Report on Form 10-K for the year ended December 31, 2010.
The
unaudited pro forma condensed combined statement of operations is not intended to reflect the results of
operations that would have resulted had the Acquisition been effective during the period presented
or the results that may be obtained by the combined company in the future. The unaudited pro forma
condensed combined statement of operations for the period presented does not reflect future events
that may occur after the Acquisition, including, but not limited to, expense efficiencies or
revenue enhancements arising from the Acquisition. It also does not give effect to certain one-time
charges that MetLife, Inc. expects to incur such as restructuring and integration costs. Future
results may vary significantly from the results reflected in the unaudited pro forma condensed
combined statement of operations.
MetLife, Inc.
Unaudited Pro Forma Condensed Combined Statement of Operations
For the Year Ended December 31, 2010
Unaudited Pro Forma Condensed Combined Statement of Operations
For the Year Ended December 31, 2010
Historical | Pro Forma | Reclassification | Pro Forma | |||||||||||||||||||
MetLife | ALICO | Adjustments | Adjustments | Notes | Combined | |||||||||||||||||
(In millions, except per share data) | ||||||||||||||||||||||
December 31, 2010 | Eleven Months Ended October | |||||||||||||||||||||
31, 2010 | ||||||||||||||||||||||
Revenues |
||||||||||||||||||||||
Premiums |
$ | 27,394 | $ | 9,463 | $ | (160 | ) | $ | (1,123 | ) | 5(a); 6(a) | $ | 35,574 | |||||||||
Universal life and investment-type product policy fees |
6,037 | | (107 | ) | 1,123 | 4(p); 5(a) | 7,053 | |||||||||||||||
Net investment income |
17,615 | 3,734 | (857 | ) | | 4(a) | 20,492 | |||||||||||||||
Other revenues |
2,328 | 5 | | | 2,333 | |||||||||||||||||
Net investment gains (losses) |
(657 | ) | (98 | ) | (229 | ) | | 4(s); 4(t); 6(a); 6(b) | (984 | ) | ||||||||||||
Total revenues |
52,717 | 13,104 | (1,353 | ) | | 64,468 | ||||||||||||||||
Expenses |
||||||||||||||||||||||
Policyholder benefits and claims |
29,545 | 7,596 | (324 | ) | (2,135 | ) | 4(q); 4(r); 4(v); 5(b); 6(a) | 34,682 | ||||||||||||||
Interest credited to policyholder account balances |
4,925 | | | 2,135 | 5(b) | 7,060 | ||||||||||||||||
Policyholder dividends |
1,486 | | | | 1,486 | |||||||||||||||||
Other expenses |
12,803 | 3,790 | (1,186 | ) | | 4(b) | 15,407 | |||||||||||||||
Total expenses |
48,759 | 11,386 | (1,510 | ) | | 58,635 | ||||||||||||||||
Income from continuing operations before provision for income tax |
3,958 | 1,718 | 157 | | 5,833 | |||||||||||||||||
Provision for income tax expense |
1,181 | 554 | 98 | | 4(u) | 1,833 | ||||||||||||||||
Income from continuing operations, net of income tax |
2,777 | 1,164 | 59 | | 4,000 | |||||||||||||||||
Less: Net income (loss) attributable to noncontrolling interests |
(4 | ) | 36 | | | 32 | ||||||||||||||||
Income from continuing operations, net of income tax, attributable to shareholders |
2,781 | 1,128 | 59 | | 3,968 | |||||||||||||||||
Less: Preferred stock dividends |
122 | | | | 122 | |||||||||||||||||
Income from continuing operations, net of income tax, attributable to common shareholders |
$ | 2,659 | $ | 1,128 | $ | 59 | $ | | $ | 3,846 | ||||||||||||
Earnings Per Share |
||||||||||||||||||||||
Income per share from continuing operations, net of income tax, attributable to common shareholders |
||||||||||||||||||||||
Basic |
$ | 3.01 | $ | 3.64 | ||||||||||||||||||
Diluted |
$ | 2.99 | $ | 3.62 | ||||||||||||||||||
Weighted average number of common shares outstanding |
||||||||||||||||||||||
Basic |
882 | 1,056 | ||||||||||||||||||||
Diluted |
890 | 1,063 | ||||||||||||||||||||
See accompanying notes to unaudited pro forma condensed combined statement of operations
MetLife, Inc.
Notes to Unaudited Pro Forma Condensed Combined Statement of Operations
Notes to Unaudited Pro Forma Condensed Combined Statement of Operations
1. Description of Transaction
Under the terms of the Stock Purchase Agreement, on November 1, 2010, MetLife, Inc. (i) paid $7.2
billion to ALICO Holdings in cash, and (ii) issued to ALICO Holdings (a) 78,239,712 shares of
MetLife, Inc.s common stock, (b) 6,857,000 shares of Series B Contingent Convertible Junior
Participating Non-Cumulative Perpetual Preferred Stock (the Series B Preferred Stock) of MetLife,
Inc., and (c) 40,000,000 equity units of MetLife, Inc. with an aggregate stated amount at issuance
of $3.0 billion, initially consisting of (x) purchase contracts obligating the holder to purchase,
on specified future settlement dates, a variable number of shares of MetLife, Inc.s common stock
for a fixed price; and (y) an interest in each of three series of debt securities (the Debt
Securities) issued by MetLife, Inc.
2. Basis of Presentation
The unaudited pro forma condensed combined statement of operations is based on the historical
financial statements of MetLife, Inc. and ALICO and combines the condensed consolidated statement
of operations for the year ended December 31, 2010, for MetLife, Inc. (which includes ALICOs
operations for the month of November 2010) and the combined statement of income for the eleven
months ended October 31, 2010, for ALICO. For ease of reference, all pro forma adjustments
reference MetLife, Inc.s December 31, 2010 year end date and no adjustments were made to ALICOs
reported information for its different period-end date. Certain adjustments and reclassifications
have been recorded in the unaudited pro forma condensed combined statement of operations to conform
to MetLife, Inc.s accounting policies and are more fully described in Notes 4 and 5. The unaudited
pro forma condensed combined statement of operations gives effect to the Acquisition as if it had
occurred on January 1, 2010.
The unaudited pro forma condensed combined statement of operations is presented in accordance with
the requirements of Article 11 of Regulation S-X published by the U.S. Securities and Exchange
Commission. In accordance with Article 11 of Regulation S-X, discontinued operations and the
related earnings per share data have been excluded from the presentation of the unaudited pro forma
condensed combined statement of operations.
The unaudited pro forma condensed combined statement of operations and accompanying notes present
the impact of the Acquisition on MetLife, Inc.s results of operations under the acquisition method
of accounting. The acquisition method of accounting requires, among other things, that the
consideration transferred be measured at fair value at the acquisition date and that assets
acquired and liabilities assumed be recognized at their fair values as of the acquisition date.
Accordingly, for purposes of determining the pro forma adjustments in the condensed combined
statement of operations, the assets acquired and liabilities assumed were assumed to have been
recorded as of the acquisition date of January 1, 2010 at their respective fair values.
The pro forma adjustments reflecting the acquisition are based on certain estimates and
assumptions. MetLife, Inc.s management believes that the pro forma adjustments give appropriate
effect to those assumptions and are properly applied in the unaudited pro forma condensed combined
statement of operations.
The unaudited pro forma condensed combined statement of operations is not intended to reflect the
results of operations of the combined company that would have resulted had the Acquisition been
effective during the period presented or the results that may be obtained by the combined company
in the future.
3. Acquisition-Related Costs
During the year ended December 31, 2010, MetLife, Inc. incurred acquisition-related transaction
costs, consisting primarily of investment banking and legal fees, of $106 million. This amount is
reflected in MetLife, Inc.s historical consolidated statement of operations for the year ended
December 31, 2010 and was included in other expenses. A pro forma adjustment has been made to
eliminate these costs from the unaudited pro forma condensed combined statement of operations for
the year ended December 31, 2010 due to their non-recurring nature.
4. Pro Forma Adjustments
The following pro forma adjustments are included in the unaudited pro forma condensed combined
statement of operations:
(a) | Adjustments to reflect the increase/(decrease) in net investment income for the year ended December 31, 2010 as follows: |
For the Year Ended | Note | |||||||
December 31, 2010 | Reference | |||||||
(in millions) | ||||||||
Adjustment to income associated with commercial mortgage-backed securities |
$ | 6 | 4 | (c) | ||||
Adjustment to amortization/accretion of fixed maturities available-for-sale portfolio |
(777 | ) | 4 | (c) | ||||
Elimination of interest income on investment in MetLife, Inc. debt securities |
(8 | ) | 4 | (c) | ||||
Adjustment to net investment income associated with reclass of investment securities |
(35 | ) | 4 | (d) | ||||
Adjustment to commercial mortgage loan income |
45 | 4 | (e) | |||||
Adjustment to income associated with policy loans |
(43 | ) | 4 | (f) | ||||
Recognition of income on indemnification asset |
2 | 4 | (g) | |||||
Adjustment to depreciation expense on investment real estate |
1 | 4 | (l) | |||||
Elimination of net investment income associated with Peru joint ventures |
(48 | ) | 6 | (a) | ||||
$ | (857 | ) | ||||||
(b) | Adjustments to reflect the (decrease)/increase in other expenses for the year ended December 31, 2010 are is as follows: |
For the Year Ended | Note | |||||||
December 31, 2010 | Reference | |||||||
(in millions) | ||||||||
Adjustment to remove acquisition-related transaction costs incurred in 2010 |
$ | (106 | ) | 3 | ||||
Elimination of interest expense on MetLife, Inc. debt securities |
(8 | ) | 4 | (c) | ||||
Elimination of amortization on historical DAC |
(1,808 | ) | 4 | (h) | ||||
Adjustment to DAC amortization related to new business |
242 | 4 | (h) | |||||
Amortization of VOBA, VODA and VOCRA |
1,202 | 4 | (i) | |||||
Amortization of negative VOBA |
(806 | ) | 4 | (j) | ||||
Elimination of expense associated with historical deferred sales inducements |
(26 | ) | 4 | (k) | ||||
Adjustment to amortization of trademark assets |
8 | 4 | (m) | |||||
Adjustment to depreciation/amortization expense associated with fixed assets and software capitalization |
(13 | ) | 4 | (n) | ||||
Recognition of interest expense on debt securities issued in connection with Acquisition |
129 | 4 | (o) | |||||
$ | (1,186 | ) | ||||||
(c) | An adjustment to decrease certain fixed maturity securities relating to commercial
mortgage-backed securities to fair value based on the Companys valuation methodology was
assumed to have been made as of January 1, 2010. The associated increase in net investment
income is $6 million for the year ended December 31, 2010 related primarily to the net change
in premium/discount of those securities. In addition, an adjustment to recognize the reduction
of $777 million for the year ended December 31, 2010 was recorded to reflect the new cost
basis and related amortization/accretion of the acquired fixed maturities available-for-sale
portfolio. |
|
The elimination of ALICOs investment in MetLife, Inc.s bonds resulted in the related
elimination of intercompany interest income/interest expense of $8 million for the year ended
December 31, 2010. |
||
(d) | An adjustment to reclassify trading securities to fixed maturity securities
available-for-sale, short term investments and cash in accordance with MetLife, Inc.s
intention not to hold the securities principally for the purpose of selling in the near term
resulted in a reduction in net investment income of $35 million for the year ended December
31, 2010. |
|
(e) | An adjustment to decrease mortgage loans to fair value resulted in an increase in net
investment income of $45 million for the year ended
December 31, 2010. |
|
(f) | An adjustment to increase policy loans to fair value resulted in a reduction in net
investment income of $43 million for the year ended December 31, 2010, related to the
amortization of premium. |
(g) | An adjustment related to the change in value of indemnification assets established for
potential recoveries related to the deterioration of fixed maturity securities (including
commercial mortgage-backed securities), mortgage loans and certain investment funds resulted
in an increase in net investment income of $2 million for the year ended December 31, 2010. |
|
(h) | An adjustment to eliminate ALICOs historical deferred policy acquisition costs (DAC)
resulted in an amortization decrease of $1,808 million for the year ended December 31, 2010.
In addition, the adjustment to increase other expenses for the DAC amortization related to new
business in the period presented in conformity with MetLife, Inc.s accounting policy is $242
million for the year ended December 31, 2010. |
|
(i) | Adjustments to establish the value of business acquired (VOBA), the value of distribution
agreements acquired (VODA) and the value of customer relationships acquired (VOCRA)
arising from the Acquisition resulted in an adjustment for the related amortization for VOBA,
VODA and VOCRA of $1,202 million for the year ended December 31, 2010. |
|
(j) | For certain acquired blocks of business, the estimated fair value of acquired liabilities
exceeded the initial policy reserves assumed at the acquisition date, resulting in a negative
VOBA which resulted in an adjustment for the related amortization for negative VOBA of $806
million for the year ended December 31, 2010. |
|
(k) | An adjustment to eliminate ALICOs deferred sales inducement assets resulted in a reduction
in amortization of $26 million for the year ended December 31, 2010. |
|
(l) | An adjustment to increase investment real estate to fair value resulted in an increase in net
investment income of $1 million for the year ended December 31, 2010. |
|
(m) | An adjustment to recognize the trademark values acquired as an identifiable intangible asset
arising from the Acquisition resulted in an adjustment for trademark amortization of $8
million for the year ended December 31, 2010. |
|
(n) | An adjustment to reduce fixed assets and capitalized software to conform to MetLife, Inc.s
capitalization policy resulted in a reduction in depreciation expense of $13 million for the
year ended December 31, 2010. |
|
(o) | An adjustment to reflect the issuance of the Debt Securities of $3.0 billion and the public
offering of senior notes issued in August, 2010 of $3.0 billion in connection with the
Acquisition was assumed to have been made as of January 1, 2010 and the increase in other
expenses related to interest expense related to the Debt Securities and the senior notes is
$129 million for the year ended December 31, 2010. Interest expense on the Debt Securities was
based on an average annual contractual rate of 1.98%. Interest expense on the public offering
of senior debt was calculated based on actual borrowing rates for the $3.0 billion in
aggregate principal amount of senior notes. |
|
(p) | An adjustment to eliminate ALICOs historical unearned revenue is $107 million for the year
ended December 31, 2010. |
|
(q) | Adjustment to remove the effects of changes in embedded derivatives on certain U.K. unit
linked business contracts which reduce earnings by $99 million for the year ended December 31,
2010 since the related guarantees will not impact MetLife, Inc.s future earnings based on the
provisions of the Stock Purchase Agreement. |
|
(r) | Adjustment to decrease policyholder benefits and claims incurred by $107 million for the year
ended December 31, 2010 for the estimated effects of unlocking actuarial assumptions used in
determining future net benefit premiums for certain traditional life insurance blocks of
business and to reverse the mark to market effects of the fair value option used by ALICO for
certain single premium variable life products in Japan as MetLife, Inc. did not exercise such
a fair value election. |
|
(s) | Adjustment to reverse realized investment losses of $83 million for the year ended December
31, 2010, to conform to MetLife, Inc.s policy related to foreign exchange. |
(t) | Adjustment to realize a net investment loss of $9 million related to the release of
unrealized gains/losses to realized gains/losses on foreign currency denominated fixed
maturity securities for the year ended December 31, 2010. |
|
(u) | The unaudited pro forma condensed combined statements of operations pre-tax adjustments were tax
effected at the U.S. tax rate of 35%. For purposes of the unaudited pro forma condensed
statements of operations, it has been assumed that earnings of foreign subsidiaries will not
be permanently reinvested. For the year ended December 31, 2010, the pro forma pre-tax
adjustments resulted in an increase to income tax expense of $98 million. |
|
(v) | Adjustment to record an increase in indemnification assets of $138 million associated with
certain litigation matters, which offsets the related litigation charge reflected in ALICOs
statement of income for the eleven months ended October 31, 2010. |
5. Reclassification Adjustments
The following reclassification adjustments have been made to conform ALICOs accounting policies to
those of MetLife, Inc. which have been recorded in the unaudited pro forma condensed combined
statement of operations:
(a) | Adjustment to reclassify universal life and investment-type product policy fees of $1,123
million from premiums for the year ended December 31, 2010. |
|
(b) | Adjustment to reclassify interest credited to policyholder account balances of $2,135 million
from policyholder benefits and claims for the year ended December 31, 2010. |
6. Pre Closing Activities
(a) On October 27, 2010, ALICO sold its investments in two joint ventures in Peru resulting in a
gain of $83 million, which has been eliminated in the unaudited pro forma condensed combined
statement of operations. In addition, the statement of operations items related to the Peru joint
ventures have been eliminated in the unaudited pro forma condensed combined statement of operations
for the year ended December 31, 2010 and are presented below.
Eleven Months Ended | ||||
October 31, 2010 | ||||
Revenues | (in millions) | |||
Premiums |
$ | 160 | ||
Net investment income |
48 | |||
Net investment gains |
5 | |||
Expenses |
||||
Policyholder benefits and claims |
178 | |||
Net income attributable to noncontrolling interests |
22 |
(b) Prior to the closing of the Acquisition, AIG was required to complete certain transactions
that affect ALICO, as required by the Stock Purchase Agreement. As a result, the following
adjustments to eliminate gains were made in the unaudited pro forma condensed combined statement of
operations for the year ended December 31, 2010:
(i) a gain of $29 million for the year ended December 31, 2010 associated with an
intercompany settlement of a foreign currency derivative between the ALICO and AIG;
(ii) a gain of $78 million for the year ended December 31, 2010, associated with the
intercompany settlement of swap positions between the ALICO and AIG Financial Products; and
(iii) a gain of $108 million for the year ended December 31, 2010, associated with the sale
of AIG common stock to AIG.
7. Pro Forma Earnings Per Share
The pro forma basic and diluted earnings per share amounts presented in the unaudited pro forma
condensed combined statement of operations are based upon the estimated weighted average number of
common shares outstanding, as adjusted for the following items:
(i) | the public offering of 86,250,000 shares of MetLife, Inc. common stock issued on August 6,
2010, in connection with financing the cash portion of the transaction; |
|
(ii) | the issuance of 78,239,712 shares of MetLife, Inc. common stock to ALICO Holdings; and | |
(iii) | conversion of the Series B Preferred Stock into 68,570,000 shares of MetLife, Inc. common stock. |
Year Ended | ||||
December 31, 2010 | ||||
Basic | (in millions) | |||
Weighted average common shares outstanding, as reported (1) |
823 | |||
Common shares issued in connection with the Acquisition (2) |
164 | |||
Common shares upon conversion of Series B Preferred Stock (3) |
69 | |||
Weighted average common shares outstanding, pro forma |
1,056 | |||
Diluted |
||||
Weighted average common shares outstanding, as reported (1) |
830 | |||
Common shares issued in connection with the Acquisition (2) |
164 | |||
Common shares upon conversion of Series B Preferred Stock (3) |
69 | |||
Weighted average common shares outstanding, pro forma |
1,063 | |||
(1) | Weighted average common shares, as reported for both basic and diluted, are
adjusted to remove the incremental common shares associated with common stock issued on
August 6, 2010, as well as the incremental common shares associated with the common stock
and the Series B Preferred Stock issued to ALICO Holdings on November 1, 2010 in
connection with the Acquisition. The shares associated with common stock are included in
the total Common shares issued in connection with the Acquisition and assumed to be
outstanding for the entire 2010 year. The shares associated with the Series B Preferred
Stock are included in the total Common shares upon conversion of Series B Preferred
Stock and are assumed to be outstanding for the entire 2010 year. |
|
(2) | Includes shares issued on August 6, 2010 as well as shares of MetLife, Inc. common
stock issued to ALICO Holdings on November 1, 2010. |
|
(3) | For purposes of the earnings per share calculation, the Series B Preferred Stock is
treated on an as-converted basis for both basic and diluted weighted average shares. |
8. Forward Looking Statements
The unaudited pro forma condensed combined statement of operations may be deemed to be forward
looking statements within the meaning of the safe harbor provisions of the United States Private
Securities Litigation Reform Act of 1995. Forward looking statements are identified by words such
as anticipate, estimate, expect, project, intend, plan, believe and other words and
terms of similar meaning in connection with a discussion
of future operating or financial performance. Such statements may include, but are not limited to
statements about the benefits of the Acquisition, including future financial and operating results,
the combined companys plans, objectives, expectations and intentions and other statements that are
not historical facts. These forward looking
statements are based largely on managements expectations and are subject to a number of risks and
uncertainties. Actual results could differ materially from these forward looking statements.